Study Published in JAMA Finds Tissue Valves As Safe As Mechanical Valves in Middle-Aged Patients Over the Long Term
September 30, 2014
No significant difference in 15-year survival or stroke rates in younger patients who had aortic valve replacement with bioprosthetic valves compared with mechanical valves.
Mount Sinai Heart Establishes Pioneering Center for Medical Devices to Advance Cardiovascular Medicine
June 26, 2014
Mount Sinai recruits Julie Swain, MD, to launch innovative center for consultation, clinical trial design, and testing of promising cardiac medical devices.
Mount Sinai Beth Israel Appoints New Heart Leadership Team for Cardiology and Cardiothoracic Surgery
May 8, 2014
World-renowned recruits Blase A. Carabello, MD, appointed Chair of Cardiology and John D. Puskas, MD, Chair of Cardiothoracic Surgery at Mount Sinai Beth Israel.
New Minimally Invasive Transcatheter Heart Valve Procedure Superior to Open-Heart Surgery for High Risk Patients
April 1, 2014
Mount Sinai's David H. Adams, MD, reports CoreValve U.S. Pivotal Trial results in Late-Breaking Clinical Trial Session at American College of Cardiology 2014 Scientific Session.
Innovative Cardiac Surgeon Allan S. Stewart, MD, Joins The Mount Sinai Hospital
November 6, 2013
Allan S. Stewart, MD, has been appointed Director of Aortic Surgery and Co-Director of the Valve Center in the Department of Cardiothoracic Surgery.
New Mitral Valve Disease and Repair Data to be Presented at 2011 Mitral Conclave
April 29, 2011
The 2011 Mitral Conclave is the first international two-day meeting focused specifically on mitral valve disease and mitral valve repair surgery.
Mount Sinai Performs First U.S. Implantation of New Device for Aortic Stenosis
December 21, 2010
Designed to replace a diseased aortic heart valve percutaneously via a catheter, device provides an alternative to open heart surgery.
Mount Sinai Implants First New Ring to Treat One Cause of Heart Failure
September 11, 2010
Dr. David Adams invented and implanted the first tricuspid annuloplasty ring in the U.S. to treat tricuspid valve regurgitation.
Minimally Invasive Cardiac Procedure Sees Reduced Mortality Rate for Fifth Straight Year
March 8, 2010
Mount Sinai Hospital's Cardiac Catheterization Laboratory has continued success in lowering the rate of in-hospital mortality following percutaneous coronary interventions.
Trial Data Conclude That Cardiovascular Risks Associated with Vioxx Could Have Been Identified Sooner
November 23, 2009
Discovery of cardiovascular risks related to taking the anti-inflammatory drug could have occurred several years before its manufacturer pulled it from the market.
Mount Sinai First in Nation to Use Visually Guided Balloon Catheter in Cardiac Procedure
September 18, 2009
Physicians at Mount Sinai Medical Center became the first in the U.S. to ablate atrial fibrillation using the endoscopic ablation system.
Mount Sinai First in U.S. to Use Nonsurgical Technique That Eliminates Major Underlying Cause of Heart-Related Stroke
August 21, 2009
Mount Sinai physicians were the first to perform a nonsurgical procedure using sutures to tie off a left atrial appendage, the source of blood clots leading to stroke in those with atrial fibrillation.
Mount Sinai School of Medicine Significantly Improves Its U.S. News & World Report Best Graduate Schools Rankings
April 24, 2009
Over the past four years, Mount Sinai has improved in the U.S. News & World Report "America's Best Graduate Schools" rankings more than any other school in the United States, jumping from 32nd to 22nd.